Resistance to antibiotics is considered to be one of the main cause of treatment failure of
H. pylori infection, although both of high eradication rate and low side effect are almost accomplished by new triple therapy using two antibiotics.
We performed two step therapy to avoid occurrence of resistant
H. pylori and to achieve complete eradicaton finally. Lansoplazole (PPI) , amoxicillin (APMC) and mucosal protective drugs (Ecabet sodium or polaprezinc) were administered for 2 weeks as first step and metronidazole (MET) was added to them as second step in unsuccessful cases of the first step. A total of 150 patients with
H. pylori positive peptic ulcer were subjected to the first step therapy. The patients were diagnosed by
13C-urea breath test, detection of
H. pylori DNA in gastric juice by PCR, culture or histology.
Eighteen out of 35 cases, failed to eradicate with first step therapy, were subjected to examine the minimum inhibitory concentration (MIC) of AMPC, MET and clarithromycin (CAM) for
H. pylori, which taken from biopsy samples from the antrum, by agar plate dilution method. All of 18 strains were sensitive (MIC≦0.10μg/m
l) to both AMPC and CAM, while 3 strains (16.7%) showed MIC of MET ranging from 3.13to 50.0μg/m
l.
Two step therapy has excellent merits that it is rare to induce antibiotics resistant
H. pylori by the first step therapy. Furthermore drug sensitivity test could be done for the selection of adequate antibiotics before the second step therapy.
抄録全体を表示